Wedbush Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $26.00
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective trimmed by Wedbush from $34.00 to $26.00 in a research note published on Wednesday,Benzinga reports. The firm currently has a neutral rating on the stock. Wedbush also issued estimates for Vera Therapeutics’ Q2 2025 earnings at ($0.71) EPS, Q3 2025 earnings at ($0.81) EPS, Q4 […]
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective trimmed by Wedbush from $34.00 to $26.00 in a research note published on Wednesday,Benzinga reports. The firm currently has a neutral rating on the stock. Wedbush also issued estimates for Vera Therapeutics’ Q2 2025 earnings at ($0.71) EPS, Q3 2025 earnings at ($0.81) EPS, Q4 […]
